Skip to main content

Pathophysiology of Restrictive Procedures

  • Chapter
Principles of Metabolic Surgery

Abstract

There are three different types of restrictive surgical procedures for morbid obesity: vertical banded gastroplasty (VBG), adjustable gastric banding (AGB), and sleeve gastrectomy (SG). These procedures are currently realized via laparoscopy. The mechanism of VBG is related to the size of the gastric pouch and to the calibrated outlet. After a solid meal, patients describe a sensation of fullness and satiety or even epigastric or low-retrosternal discomfort, indicating pouch fullness; at this point the patient must stop eating. If eating continues, discomfort increases until voluntary or spontaneous regurgitation of the excess food occurs. Satiety is dependent on the thickness and consistency of the food eaten; hence patients who consume mainly liquids usually have less weight loss. Gastric motility may play a part in the rate of drainage of the gastric pouch, and excessive motility may be responsible for poor weight loss in some cases. The variability in weight loss after gastroplasty and other restrictive procedures highlights the fact that the final amount of weight loss depends on patient-controlled factors as well as on the surgical procedure. Following placement of laparoscopic AGB (LAGB), as soon as the patient ingests two spoonfuls the small gastric compartment above the band is filled and he or she experiences a feeling of fullness. Since it takes a long time for this compartment to empty because of the narrowed stoma, more food can be ingested only after substantial time has elapsed. The patient must therefore eat at a much slower pace, and this slower pace allows the satiety center to be stimulated. As the hunger sensation is no longer present, overall food intake is reduced. The major advantage of LAGB is the possibility to adjust the size of the outlet. Another hypothesis not confirmed as the mode of action of gastric banding was gut hormone modulation. The mechanism of action of laparoscopic SG (LSG) is not only the restriction obtained by resecting part of the body and the entire fundus of the stomach, leaving a small gastric tube of 100–150 ml. Hormonal changes following this procedure must also be considered. Ghrelin is a 28-amino-acid orexigenic peptide, secreted essentially by the fundus of the stomach, which stimulates feeding behavior and hunger. In LSG, the gastric fundus is resected and plasma ghrelin levels are expected to decrease following surgery. Another mechanism explaining weight loss after LSG could be the relationship between appetite and gastric emptying, as the gastric clearance seems to be improved.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Mason EE, Ito C (1967) Gastric bypass in obesity. Surg Clin North Am 47:1345–1351

    PubMed  CAS  Google Scholar 

  2. Printen KJ, Mason EE (1973) Gastric surgery for relief of morbid obesity. Arch Surg 106:428–431

    Article  PubMed  CAS  Google Scholar 

  3. Gomez CA (1979) Gastroplasty in morbid obesity. Surg Clin North Am 59:1113–1120

    PubMed  CAS  Google Scholar 

  4. Mason EE (1982) Vertical banded gastroplasty. Arch Surg 117:701–706

    Article  PubMed  CAS  Google Scholar 

  5. Mason EE (2003) Development and future of gastroplasties for morbid obesity. Arch Surg 138:361–366

    Article  PubMed  Google Scholar 

  6. Laws HL, Piatadosi S (1981) Superior gastric reduction procedure for morbid obesity: a prospective, randomized trial. Am J Surg 193:334–336

    CAS  Google Scholar 

  7. Chua TY, Mendiola RM (1995) Laparoscopic vertical banded gastroplasty. Obes Surg 5:77–80

    Article  PubMed  Google Scholar 

  8. Morino M, Toppino M, Bonnet G, Rosa R, Garrone C Laparoscopic vertical banded gastroplasty for morbid obesity. Assessment of efficacy. Surg Endosc 2002 16:1566–1572

    Article  PubMed  CAS  Google Scholar 

  9. Wang W, Yu PJ, Lee YC, Wei PL, Lee WJ (2005) Laparoscopic vertical banded gastroplasty: 5-year results. Obes Surg 15:1299–1303

    Article  PubMed  Google Scholar 

  10. Wilkinson LH, Peloso OA (1981) Gastric (reservoir) reduction for morbid obesity. Arch Surg 116:602–605

    Article  PubMed  CAS  Google Scholar 

  11. Kolle K (1982) Gastric banding (abstract). OMGI 7th Congress, Stockholm, 37:145

    Google Scholar 

  12. Molina, K, Oria HE (1983) Gastric segmentation: a new safe, effective, simple, readily revised and fully reversible surgical procedure for the correction of morbid obesity (abstract). 6th Bariatric Surgery Colloquium, Iowa City, June 2–3

    Google Scholar 

  13. Buchwald H (2002) Overview of bariatric surgery. J Am Coll Surg 194:367–375

    Article  PubMed  Google Scholar 

  14. Vassallo C, Andreoli M, La Manna A et al (2002) 60 reoperations on 890 patients after gastric restrictive surgery. Obes Surg 11:752–756

    Article  Google Scholar 

  15. Kuzmak LI (1986) Silicone gastric banding: a simple and effective operation for morbid obesity. Contemp Surg 28:13–18

    Google Scholar 

  16. Forsell P, Hallberg D, Hellers G (1993) A gastric band with adjustable inner diameter for obesity surgery: preliminary studies. Obes Surg 3:303–306

    Article  PubMed  Google Scholar 

  17. Cadiere GB, Bruyns J, Himpens J, Favretti F (1994) Laparoscopic gastroplasty for morbid obesity. Br J Surg 81:1524

    Article  PubMed  CAS  Google Scholar 

  18. Bioenterics (INAMED) (2001) LAP-BAND Adjustable Gastric Banding System, US approved labeling, June 13

    Google Scholar 

  19. Schindler K, Prager G, Ballaban T et al (2004) Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest 34:549–554

    Article  PubMed  CAS  Google Scholar 

  20. Uzzan B, Catheline JM, Lagorce C et al (2007) Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patients. Obes Surg 17:1159–1164

    Article  PubMed  Google Scholar 

  21. Ram E, Vishne T, Diker D et al (2005) Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA-S levels. Obes Surg 15:1118–1123

    Article  PubMed  Google Scholar 

  22. Hanusch-Enserer U, Cauza E, Brabant G et al (2004) Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding. J Clin Endocrinol Metab 89:3352–3358

    Article  PubMed  CAS  Google Scholar 

  23. Kojima M, Hosoda H, Date Y et al (1999) Ghrelin is a growthhormone- releasing acylated peptide from stomach. Nature 402:656–660

    Article  PubMed  CAS  Google Scholar 

  24. Le Roux CW, Aylwin SJ, Batterham RL et al (2006) Gut hormone profiles following bariatric surgery favor an anoretic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243:108–114

    Article  PubMed  Google Scholar 

  25. Hess DS, Hess DW (1988) Biliopancreatic diversion with a duodenal switch. Obes Surg 8:267–282

    Article  Google Scholar 

  26. Fried M (2008) The current science of gastric banding: an overview of pressure-volume theory in band adjustement. Surg Obes Relat Dis 4:S14-S21

    Article  PubMed  Google Scholar 

  27. Marceau P, Hould FS, Simard S et al (1998) Biliopancreatic diversion with duodenal switch. World J Surg 22:947–954

    Article  PubMed  CAS  Google Scholar 

  28. Johnston D, Dachtler J, Sue-Ling HM, King RF, Martin G (2003) The Magenstrasse and Mill operation for morbid obesity. Obes Surg 13:10–16

    Article  PubMed  Google Scholar 

  29. Silecchia GF, Boru C, Pecchia A et al (2006) Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg 16:1138–1144

    Article  PubMed  Google Scholar 

  30. Mognol P, Chosidow D, Marmuse JP (2005) Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg 15:1030–1033

    Article  PubMed  Google Scholar 

  31. Gagner M, Inabnet WB, Pomp A (2005) Laparoscopic sleeve gastrectomy with second stage biliopancreatic diversion and duodenal switch in the superobese. In: Inabnet WB, DeMaria EJ, Ikramuddin S (eds) Laparoscopic bariatric surgery. Lippincott William & Wilkins. Philadelphia pp 143–50

    Google Scholar 

  32. Almogy G, Crookes PF, Anthone GJ (2004) Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg 14:492–497

    Article  PubMed  Google Scholar 

  33. Baltasar A, Serra C, Perez N, Bou R, Bengochea M, Ferri L(2005) Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg 15:1124–1128

    Article  PubMed  Google Scholar 

  34. Cottam D, Qureshi FG, Mattar SG et al (2006) Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 20:859–863

    Article  PubMed  CAS  Google Scholar 

  35. Robinson J, Sue-Ling H, Johnston D (2006) The Magenstrasse and Mill procedure can be combined with a Roux-en-Y gastric bypass to produce greater and sustained weight loss. Obes Surg 16:891–896

    Article  PubMed  Google Scholar 

  36. Nguyen NT, Longoria M, Gelfand DV, Sabio A, Wilson SE (2005) Staged laparoscopic Roux-en-Y: a novel two-stage bariatric operation as an alternative in the super-obese with massively enlarged liver. Obes Surg 15:1077–1081

    Article  PubMed  Google Scholar 

  37. Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super super-obese patients. Obes Surg 13:861–864

    Article  PubMed  CAS  Google Scholar 

  38. Vidal J, Ibarzabal A, Nicolau J et al (2007) Short-term effects of sleeve gastrectomy on type-2 diabetes mellitus in severely obese subjects. Obes Surg 17:1069–1074

    Article  PubMed  CAS  Google Scholar 

  39. Fruhbeck G, Diez-Caballero A, Gil MJ et al (2004) The decrease in plasma ghrelin concentrations following bariatric surgery on the functional integrity of the fundus. Obes Surg 14:606–612

    Article  PubMed  Google Scholar 

  40. Langer FB, Reza Hoda MA, Bohdjalian A et al (2005) Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 15:1024–1029

    Article  PubMed  CAS  Google Scholar 

  41. Himpens J, Dapri G, Cadiere GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16:1450–1456

    Article  PubMed  Google Scholar 

  42. Cohen R, Uzzan B, Bihan H, Khochtali I, Reach G, Catheline JM (2005) Ghrelin levels and sleeve gastrectomy in super superobesity. Obes Surg 15:1501–1502

    Article  PubMed  Google Scholar 

  43. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247:401–407

    Article  PubMed  Google Scholar 

  44. Bergmann JF, Chassany O, Petit A et al (1992) Correlation between echographic gastric emptying and appetite: influence of psyllium. Gut 33:1042–1043

    Article  PubMed  CAS  Google Scholar 

  45. Carmichael AR, Johnston D, Baker MC et al (2001) Gastric emptying after a new, more physiological anti-obesity operation: the Magenstrasse and Mill procedure. Eur J Nucl Med 28:1379–1383

    Article  PubMed  CAS  Google Scholar 

  46. Melissas J, Koukouraki S, Askoxylakis J et al (2007) Sleeve gastrectomy: a restrictive procedure? Obes Surg 17:57–62

    Article  PubMed  Google Scholar 

  47. Gagner M (2008) Sleeve gastrectomy provides resolution of type-2 diabetes without duodenal exclusion. The 2007 International Consensus Summit on Sleeve Gastrectomy. Bariatric Times. Clinical developments and metabolic insights in total bariatric patient care. June Supplement A, pp 5–6

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dapri, G., Cadière, G.B., Himpens, J. (2012). Pathophysiology of Restrictive Procedures. In: Karcz, W.K., Thomusch, O. (eds) Principles of Metabolic Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02411-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-02411-5_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-02410-8

  • Online ISBN: 978-3-642-02411-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics